Zheng MH - Search Results

1

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1.

Zhu GQ, Zou ZL, Zheng JN, Chen DZ, Zou TT, Shi KQ, Zheng MH. Zhu GQ, et al. Among authors: zheng mh, zheng jn. Medicine (Baltimore). 2016 Mar;95(9):e3004. doi: 10.1097/MD.0000000000003004. Medicine (Baltimore). 2016. PMID: 26945424 Free PMC article. Review.

2

Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.

Zheng M, Chen Y, Yang X, Li J, Zhang Y, Zeng Q. Zheng M, et al. BMC Gastroenterol. 2007 Feb 12;7:6. doi: 10.1186/1471-230X-7-6. BMC Gastroenterol. 2007. PMID: 17295917 Free PMC article.

3

The quality of randomized controlled trials on DanShen in the treatment of ischemic vascular disease.

Yu S, Zhong B, Zheng M, Xiao F, Dong Z, Zhang H. Yu S, et al. J Altern Complement Med. 2009 May;15(5):557-65. doi: 10.1089/acm.2008.0436. J Altern Complement Med. 2009. PMID: 19425821 Review.

4

Tumor necrosis factor-alpha-308A allele may have a protective effect for chronic hepatitis B virus infection in Mongoloid populations.

Zheng MH, Qiu LX, Xin YN, Pan HF, Shi KQ, Chen YP. Zheng MH, et al. Int J Infect Dis. 2010 Jul;14(7):e580-5. doi: 10.1016/j.ijid.2009.08.010. Epub 2009 Dec 9. Int J Infect Dis. 2010. PMID: 20004605 Free article.

5

A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.

Zheng MH, Shi KQ, Dai ZJ, Ye C, Chen YP. Zheng MH, et al. Clin Ther. 2010 Apr;32(4):649-58. doi: 10.1016/j.clinthera.2010.04.001. Clin Ther. 2010. PMID: 20435234 Clinical Trial.

6

A model to determine 3-month mortality risk in patients with acute-on-chronic hepatitis B liver failure.

Zheng MH, Shi KQ, Fan YC, Li H, Ye C, Chen QQ, Chen YP. Zheng MH, et al. Clin Gastroenterol Hepatol. 2011 Apr;9(4):351-356.e3. doi: 10.1016/j.cgh.2010.12.027. Epub 2010 Dec 31. Clin Gastroenterol Hepatol. 2011. PMID: 21195790

7

Meta-analysis using individual participant data is the gold standard for diagnostic studies.

Zheng MH, Shi KQ, Fan YC, Chen YP. Zheng MH, et al. Hepatology. 2011 Mar;53(3):1062; author reply 1062-3. doi: 10.1002/hep.24188. Hepatology. 2011. PMID: 21374680 No abstract available.

8

Methodological quality assessment for traditional Chinese medicine: CONSORT is better.

Zheng MH, Fan YC, Shi KQ, Chen YP. Zheng MH, et al. Hepatology. 2011 Jun;53(6):2148-9. doi: 10.1002/hep.24126. Epub 2011 Apr 6. Hepatology. 2011. PMID: 21472741 No abstract available.

9

Risk stratification of spontaneous bacterial peritonitis in cirrhosis with ascites based on classification and regression tree analysis.

Shi KQ, Fan YC, Ying L, Lin XF, Song M, Li LF, Yu XY, Chen YP, Zheng MH. Shi KQ, et al. Among authors: zheng mh. Mol Biol Rep. 2012 May;39(5):6161-9. doi: 10.1007/s11033-011-1432-8. Epub 2011 Dec 29. Mol Biol Rep. 2012. PMID: 22205541

10

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Shi KQ, Fan YC, Liu WY, Li LF, Chen YP, Zheng MH. Shi KQ, et al. Among authors: zheng mh. Mol Biol Rep. 2012 Oct;39(10):9715-22. doi: 10.1007/s11033-012-1836-0. Epub 2012 Jun 21. Mol Biol Rep. 2012. PMID: 22718512 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

810 results

Search Page

Filters